Drug Shortage Report for PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION

Last updated on 2020-09-15 History
Report ID 119480
Drug Identification Number 02330547
Brand name PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION
Common or Proper name PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) PIPERACILLIN TAZOBACTAM
Strength(s) 12G 1.5G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 PSOIJ CA
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2020-07-03
Estimated end date 2020-08-31
Actual end date 2020-09-11
Shortage status Resolved
Updated date 2020-09-15
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-09-15 French Compare
v5 2020-09-15 English Compare
v4 2020-08-17 French Compare
v3 2020-08-17 English Compare
v2 2020-07-06 French Compare
v1 2020-07-06 English Compare